Bluebird Bio (BLUE) Price Target Raised to $120 at Roth

December 29, 2014 7:55 AM EST Send to a Friend

Roth Capital maintained a Buy rating on Bluebird Bio (NASDAQ ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Bluebird Bio (BLUE) Price Target Raised to $120 at Roth

Member Login

Free News Feed